MURA, Maria Stella Anna
 Distribuzione geografica
Continente #
NA - Nord America 3.476
AS - Asia 2.086
EU - Europa 1.215
SA - Sud America 1.079
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
Totale 7.944
Nazione #
US - Stati Uniti d'America 3.405
BR - Brasile 982
SG - Singapore 787
CN - Cina 687
UA - Ucraina 391
HK - Hong Kong 178
DE - Germania 177
FR - Francia 146
VN - Vietnam 144
SE - Svezia 116
IT - Italia 93
GB - Regno Unito 80
FI - Finlandia 68
IN - India 46
BD - Bangladesh 38
IQ - Iraq 33
MX - Messico 30
RU - Federazione Russa 30
AR - Argentina 28
TR - Turchia 26
EC - Ecuador 20
ES - Italia 20
BE - Belgio 19
CA - Canada 19
PK - Pakistan 17
CZ - Repubblica Ceca 16
ZA - Sudafrica 15
IR - Iran 14
PL - Polonia 14
MA - Marocco 13
VE - Venezuela 13
TN - Tunisia 12
CO - Colombia 11
JP - Giappone 11
KR - Corea 11
AE - Emirati Arabi Uniti 10
JO - Giordania 10
PE - Perù 9
UZ - Uzbekistan 9
NP - Nepal 8
AT - Austria 7
AU - Australia 7
AZ - Azerbaigian 7
ID - Indonesia 7
PY - Paraguay 7
CR - Costa Rica 6
EG - Egitto 6
SA - Arabia Saudita 6
EU - Europa 5
KE - Kenya 5
KZ - Kazakistan 5
LT - Lituania 5
PA - Panama 5
UY - Uruguay 5
BG - Bulgaria 4
CH - Svizzera 4
IE - Irlanda 4
IL - Israele 4
KG - Kirghizistan 4
NG - Nigeria 4
NL - Olanda 4
OM - Oman 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
GT - Guatemala 3
HN - Honduras 3
QA - Qatar 3
RS - Serbia 3
SN - Senegal 3
BY - Bielorussia 2
CG - Congo 2
CL - Cile 2
DZ - Algeria 2
JM - Giamaica 2
KW - Kuwait 2
MD - Moldavia 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KI - Kiribati 1
LB - Libano 1
LY - Libia 1
MM - Myanmar 1
NI - Nicaragua 1
Totale 7.938
Città #
Dallas 1.078
Singapore 479
Chandler 380
San Jose 357
Jacksonville 237
Hong Kong 177
Beijing 167
Ashburn 135
Princeton 130
Nanjing 102
Dearborn 68
Lauterbourg 61
Ann Arbor 60
New York 55
São Paulo 55
Ho Chi Minh City 53
Wilmington 52
Boardman 49
Shanghai 44
Nanchang 43
Shenyang 41
Hanoi 36
Los Angeles 35
Rio de Janeiro 33
Santa Clara 33
Woodbridge 30
Sassari 28
Belo Horizonte 26
Munich 25
Tianjin 25
Curitiba 23
Hebei 23
Ningbo 20
Brussels 19
Columbus 19
Jinan 18
Brasília 16
Changsha 16
Porto Alegre 16
The Dalles 16
Council Bluffs 15
London 15
Buffalo 14
Nuremberg 14
Warsaw 14
Zhengzhou 14
Baghdad 13
Brno 13
Brooklyn 13
Guangzhou 13
Ardabil 12
Chennai 12
Madrid 12
Hangzhou 11
Houston 11
Orem 11
Poplar 11
Seoul 11
Amman 10
Andover 10
Norwalk 10
Denver 9
Dhaka 9
Guarulhos 9
Kunming 9
Mumbai 9
San Francisco 9
Tashkent 9
Tunis 9
Campinas 8
Da Nang 8
Frankfurt am Main 8
Leawood 8
Mexico City 8
Natal 8
Phoenix 8
Ribeirão Preto 8
Rome 8
São Bernardo do Campo 8
Tokyo 8
Turku 8
Uberlândia 8
Atlanta 7
Changchun 7
Chicago 7
Helsinki 7
Izmir 7
Juiz de Fora 7
Monmouth Junction 7
Recife 7
San Mateo 7
Taizhou 7
Auburn Hills 6
Augusta 6
Baku 6
Campo Grande 6
Fortaleza 6
Goiânia 6
Haiphong 6
Johannesburg 6
Totale 4.833
Nome #
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 279
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 223
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 213
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 201
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 190
Analisi delle Dual Therapy nei pazienti con HIV: Aspetti farmacoeconomici-epidemiologici e clinici 190
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 175
Acute respiratory distress syndrome due to influenza virus A/H1N1v in a patient with HIV/HCV co-infection 172
Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era 167
Associazione sierologia tra HIV e Trichomonas vaginalis nella popolazione femminile del Nord-Sardegna. 161
Dental care and HIV-infected individuals: are they equally treated? 156
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy 149
Trends in the European HIV/AIDS epidemic: a perspective from Italy 149
13. Socio-demographic and climatic factors as correlates of Mediterranean spotted fever (MSF) in northern Sardinia. 148
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 147
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project 144
Andamento delle infezioni nosocomiali nel complesso chirurgico Università- Azienda USL n. 1- Sassari. 143
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 141
Identification of HIV patients with active pulmonary tuberculosis using urine based polymerase chain reaction assay 140
Pneumococcal pneumonia: clinical features, diagnosis and management in HIV-infected and HIV non infected patients 140
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 139
Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? 139
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 138
Arboviral infections in Egyptian and Sardinian children and adults with aseptic meningitis and meningo-encephalitis 137
QuantiFERON TB Gold: a new method for latent tuberculosis infection 137
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 137
Body composition evaluation by DEXA in the follow up of HIV patients treted with HAART. 137
Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. Study. 136
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 134
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 133
Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort 133
Rapid detection and identification of Mycobacterium tuberculosis by Real Time PCR and Bactec 960 MIGT 123
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL) 121
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 120
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 119
Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy. 114
Comparison of the efficacy at 48 weeks of first-line antiretroviral treatment for HIV infection in 1998 and 2006: a multicentric investigation 113
Renal toxicity in HIV-infected patients receiving HAART including tenofovir 112
Interferon-γ release assay in people infected with immunodeficiency virus 109
Severe liver disease associated with prolonged exposure to antiretroviral drugs 103
The changing face of the HIV epidemic in Northern Sardinia: increased diagnoses among pregnant women 102
Hepatitis C Viremia in HIV/HCV-Coinfected Patients: Lower Levels in Presence of Chronic Hepatitis B 101
Usefulness of 99mTc-tetrofosmin scintigraphy in different variants of Kaposi's sarcoma. 99
Raltegravir central nervous system tolerability in clinical practice: results from a multicenter observational study 98
Distribution of the CCR5 delta32 allele in Italian HIV type 1-infected and normal individuals 96
Molecular typing of non-typhoid Salmonella strains isolated from HIV-infected patients with recurrent salmonellosis 96
Rotavirus infection in AIDS-associated diarrhoea. 96
Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study 93
Detection of Toscana virus central nervous system infections in Sardinia Island, Italy. 92
The HIV/AIDS epidemic in the Province of Sassari in the combination antiretroviral therapy era 88
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection 87
HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART 86
HIV and related infections in Italian prisons: epidemiology and health organization 84
Rickettsia monacensis as Cause of Mediterranean Spotted Fever-like Illness, Italy 82
Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort 79
Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy 78
Treatment-related factors and highly active antiretroviral therapy adherence. 75
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 75
Successful prevention of multidrug resistant HIV mother-to-child transmission with enfuvirtide use in late pregnancy 73
HIV type 1 origin and transmission dynamics among different risk groups in sardinia: molecular epidemiology within the close boundaries of an Italian island 71
L'Epidemia da HIV/AIDS in Provincia di Sassari nell'era della terapia antiretrovirale combinata 71
Prevalence and risk factors for chronic obstructive lung disease in HIV-infected patients in the HAART era 68
Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor ntiretroviral regimens failed 67
Two cases of human granulocytic ehrlichiosis in Sardinia, Italy confirmed by PCR 58
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome. 57
Efficacy of 1998vs2006 first-line antiretroviral regimens for HIV infection: an ordinary clinics retrospective investigation 56
Totale 8.090
Categoria #
all - tutte 32.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.353


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 0 0 12
2021/2022309 52 6 4 6 6 7 16 18 19 18 29 128
2022/2023694 69 53 10 145 53 129 0 57 123 10 24 21
2023/2024172 38 13 2 6 32 18 0 8 0 0 16 39
2024/20251.946 24 22 109 42 66 52 133 351 683 290 99 75
2025/20263.203 137 869 433 399 296 154 528 77 109 114 71 16
Totale 8.090